Articles

Lilly’s Effient steps forward, then back

A day after doctors were alerted to a black-box warning that could slow sales of Effient’s main competitor,
Plavix,
a medical journal published research showing that patients suffered 43-percent more cancer tumors on Effient than on Plavix.

Read More

OneAmerica to acquire McCready and Keene

McCready and Keene Inc. is the fifth-largest employee benefits firm in the Indianapolis area. It employs 95 people nationally, 82 of them in Indianapolis, according to IBJ research.

Read More

Q&A

David Stocum is the director of the Center for Regenerative Biology and Medicine at the IUPUI School of Science.
He and his team are studying how amphibians regenerate parts of their bodies to see if there are ways to induce humans to
regenerate tissue that is lost or damaged. The center has about 20 researchers and funding of about $14 million to fuel its
quest.

Read More

Hospital jobs keep growing in recession

Hospitals continued to be a stable and slightly growing source of jobs and wages in Indiana—for better and for worse.
The sector paid $7.3 billion to 127,000 Hoosiers in 2008, according to the latest data from the American Hospital Association.

Read More

Medicare cuts hit doctors as Congress feuds

Physician offices will begin receiving payments from the Medicare that are 21.3-percent below
what they’ve been getting so far this year. Doctors still expect Congress to reverse the payment cuts, but physicians
and the Medicare program will have to reprocess claims, costing both extra money.

Read More

Braly’s political skirmishes hurting insurer, critics say

When WellPoint Inc. named Angela Braly its CEO three years ago, it touted her experience dealing with politicians and government
regulators. But WellPoint is now the poster child for health insurer bad behavior—credited in Washington with reviving a
dead health reform bill the company opposed.

Read More

Indy firm launches bedsore weapon

The latest idea from Dr. James Spahn, an Indianapolis health care entrepreneur, should help hospitals and nursing homes do
a better job of preventing severe bedsores, or pressure ulcers. That’s good, because Medicare and private health insurers
increasingly won’t pay to treat them.

Read More

Indiana moves up in med tech rankings

Medical technology companies employed 19,950 Hoosiers in 2007 and supported another 35,000 jobs in supplier companies, according
to an analysis funded by an industry trade group.

Read More

Research reforms will force Lilly, others to test how drugs stack up

The federal government is currently doling out $1.1 billion in stimulus funds to pay for research that compares multiple medical
treatments against one another to determine which is most effective. Drug companies like Eli Lilly and Co. are wary that comparative-effectiveness
research could threaten their sales.

Read More

Q&A

Cheryl Blanchard is chief scientific officer at Zimmer Holdings Inc. in Warsaw and chairman of OrthoWorx,
a not-for-profit initiative launched in September to help improve the growth environment for orthopedic companies in Warsaw.

Read More

Study: Online doc ratings mostly positive

Angie’s List physician rating service has been controversial since it started in 2008. But an academic journal article
is now telling the docs to relax. Nearly 90 percent of patient comments on sites like Angie’s List are positive.

Read More